Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+detection rates
Rozemeijer, Kirsten, Penning, Corine, Siebers, Albert G., Naber, Steffie K., Matthijsse, Suzette M., van Ballegooijen, Marjolein, van Kemenade, Folkert J., de Kok, Inge M. C. M.Volume:
27
Langue:
english
Journal:
Cancer Causes & Control
DOI:
10.1007/s10552-015-0678-1
Date:
January, 2016
Fichier:
PDF, 519 KB
english, 2016
File converter
Plus de résultats de recherche
More benefits 
